Article
The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
Journal of nephrology - 1 Oct 2016
Achour Ons, Elmtaoua Sahbi, Zellama Dorsaf, Omezzine Asma, Moussa Amira, Rejeb Jihene, Boumaiza Imene, Bouacida Lobna, Rejeb Nabila Ben, Achour Abdellatif, Bouslama Ali
Abstract excerpt
BACKGROUND: Hyperhomocysteinaemia, an independent risk factor for cardiovascular diseases, is common in hemodialysis patients (HD) and particularly in those homozygous for polymorphism of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene. B vitamins supplementation has been shown to lower plasma total homocysteine (tHcy), but this has been contreversed in several groups. The aim of our study was to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
